BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36686507)

  • 1. Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation.
    Yamamoto T; Yamanaka Y; Hirano S; Higuchi Y; Kuwabara S
    Front Neurol; 2022; 13():1042033. PubMed ID: 36686507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor speech effects in subthalamic deep brain stimulation for Parkinson's disease.
    Kluin KJ; Mossner JM; Costello JT; Chou KL; Patil PG
    J Neurosurg; 2022 Sep; 137(3):722-728. PubMed ID: 35090126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effects of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation on Motor Subtypes in Parkinson's Disease.
    Fan S; Liu D; Shi L; Meng F; Fang H; Liu H; Zhang H; Yang A; Zhang J
    World Neurosurg; 2022 Aug; 164():e245-e255. PubMed ID: 35489598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores.
    Goetz CG; Stebbins GT; Tilley BC
    Mov Disord; 2012 Sep; 27(10):1239-42. PubMed ID: 22886777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Subthalamic Nucleus Deep Brain Stimulation and Retention Delay on Memory-Guided Reaching Performance in People with Parkinson's Disease.
    Trevarrow MP; Munoz MJ; Rivera YM; Arora R; Drane QH; Rosenow JM; Sani SB; Pal GD; Verhagen Metman L; Goelz LC; Corcos DM; David FJ
    J Parkinsons Dis; 2023; 13(6):917-935. PubMed ID: 37522216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Iron Distribution in Deep Gray Matter Nuclei Measured by Quantitative Susceptibility Mapping and Motor Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease.
    Zhao W; Yang C; Tong R; Chen L; Chen M; Gillen KM; Li G; Ma C; Wang Y; Wu X; Li J
    J Magn Reson Imaging; 2023 Aug; 58(2):581-590. PubMed ID: 36594513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDS-UPDRS to assess non-motor symptoms after STN DBS for Parkinson's disease.
    Jafari N; Pahwa R; Nazzaro JM; Arnold PM; Lyons KE
    Int J Neurosci; 2016; 126(1):25-9. PubMed ID: 26134878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease.
    Li H; Liang S; Yu Y; Wang Y; Cheng Y; Yang H; Tong X
    PLoS One; 2020; 15(9):e0238936. PubMed ID: 32915893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of subthalamic nucleus deep brain stimulation and dopaminergic treatment on dual-task manual dexterity in Parkinson's disease.
    Gülşen Ç; Koçer B; Çomoğlu SS; Gündüz AG
    Neurol Sci; 2023 May; 44(5):1633-1641. PubMed ID: 36598618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the L-Dopa Response as a Predictor of Motor Outcomes After Deep Brain Stimulation in Parkinson's Disease.
    Lin Z; Zhang X; Wang L; Zhang Y; Zhou H; Sun Q; Sun B; Huang P; Li D
    Front Hum Neurosci; 2021; 15():604433. PubMed ID: 33613209
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Long-term Follow-up of Focused Ultrasound Unilateral Subthalamotomy for Parkinson Disease.
    Martínez-Fernández R; Natera-Villalba E; Máñez Miró JU; Rodriguez-Rojas R; Marta Del Álamo M; Pineda-Pardo JÁ; Ammann C; Obeso I; Mata-Marín D; Hernández-Fernández F; Gasca-Salas C; Matarazzo M; Alonso-Frech F; Obeso JA
    Neurology; 2023 Mar; 100(13):e1395-e1405. PubMed ID: 36631272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dorsal subthalamic deep brain stimulation improves pain in Parkinson's disease.
    Askari A; Lam JLW; Zhu BJ; Lu CW; Chou KL; Wyant KJ; Patil PG
    Front Pain Res (Lausanne); 2023; 4():1240379. PubMed ID: 37663307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Procedural Sedation on the Clinical Outcome of Microelectrode Recording Guided Deep Brain Stimulation in Patients with Parkinson's Disease.
    Bos MJ; de Korte-de Boer D; Alzate Sanchez AM; Duits A; Ackermans L; Temel Y; Absalom AR; Buhre WF; Roberts MJ; Janssen MLF
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33917205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Löser J; Luthardt J; Rullmann M; Weise D; Sabri O; Meixensberger J; Hesse S; Winkler D
    J Neurosurg; 2021 Feb; 135(5):1429-1435. PubMed ID: 33607613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.